JOURNAL OF BUON, vol.24, no.5, pp.1876-1883, 2019 (SCI-Expanded)
Purpose: This study aimed to analyze prognostic factors for survival and the reliability and the effectiveness of eribulin therapy in metastatic breast cancer (MBC) patients.